{"testuser": {"MPL c.305G>C": {"Gene Data": {"Number": 1, "Classification": "Pathogenic", "Gene": "MPL", "Exon/Intron": "1", "SNP ID": "rs28928907", "DNA change": "c.305G>C", "Protein change": "p.Arg102Pro", "Transcript ID": "ENST00000372470.9", "Zygosity": "heterozygous", "Inheritance": "AD;AR", "Associated Disease(s)": ["essential thrombocytemia", "Congenital amegakaryocytic thrombocytopenia", "Thrombocytopenia"], "Cancer Groups": ["BREAST", "GASTROINTESTINAL", "LUNG", "PROSTATE", "GENITOURINARY", "CNS", "FEMALE_REPRODUCTIVE", "SKIN", "ENDOCRINE", "HEMATOLOGIC", "MUSCULOSKELETAL"]}, "Comments": [{"clin_sig": "Pathogenic", "name": "NaN", "comment": "Variant summary: The MPL c.305G>C (p.Arg102Pro) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 56/121606 control chromosomes at a frequency of 0.0004605, which does not exceed the estimated maximal expected allele frequency of a pathogenic MPL variant (0.002357). The variant was reported in numerous CAMPT patients in the literature, both in the homozygous and compound heterozygous state. Functional studies have shown the variant to lead to abnormal subcellular receptor distribution, lack of membrane localization, impaired glycosylation as well as impaired TPO signal transduction (Stockklausner_2015, Tijssen_2008). Taken together, this variant is classified as pathogenic."}, {"clin_sig": "Pathogenic", "name": "NaN", "comment": "Variant summary: The MPL c.305G>C (p.Arg102Pro) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 56/121606 control chromosomes at a frequency of 0.0004605, which does not exceed the estimated maximal expected allele frequency of a pathogenic MPL variant (0.002357). The variant was reported in numerous CAMPT patients in the literature, both in the homozygous and compound heterozygous state. Functional studies have shown the variant to lead to abnormal subcellular receptor distribution, lack of membrane localization, impaired glycosylation as well as impaired TPO signal transduction (Stockklausner_2015, Tijssen_2008). Taken together, this variant is classified as pathogenic."}, {"clin_sig": "Pathogenic", "name": "NaN", "comment": "Variant summary: The MPL c.305G>C (p.Arg102Pro) variant involves the alteration of a conserved nucleotide. 3/4 in silico tools predict a damaging outcome for this variant (SNPs&GO not captured due to low reliability index). This variant was found in 56/121606 control chromosomes at a frequency of 0.0004605, which does not exceed the estimated maximal expected allele frequency of a pathogenic MPL variant (0.002357). The variant was reported in numerous CAMPT patients in the literature, both in the homozygous and compound heterozygous state. Functional studies have shown the variant to lead to abnormal subcellular receptor distribution, lack of membrane localization, impaired glycosylation as well as impaired TPO signal transduction (Stockklausner_2015, Tijssen_2008). Taken together, this variant is classified as pathogenic."}], "Frequencies": {"Gene": "MPL", "Transcript": "ENST00000372470.9", "DNA change": "c.305G>C", "Protein change": "p.Arg102Pro", "Genomic Location": "chr1:43338634", "Alternate Allele Fraction": "0.04%", "dbSNP rsID": "rs28928907"}, "Publications": [{"Pubmed ID": "10971406", "Title": "Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia."}, {"Pubmed ID": "18422784", "Title": "Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia."}, {"Pubmed ID": "24728327", "Title": "Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing."}, {"Pubmed ID": "32581363", "Title": "Monogenic and polygenic inheritance become instruments for clonal selection."}]}}}